What are the pediatric doses of ceftriaxone and aciclovir for a 15 kg baby?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Dosing for Ceftriaxone and Aciclovir in a 15 kg Child

Ceftriaxone Dosing

For a 15 kg child, the recommended dose of ceftriaxone is 50-75 mg/kg/day, which equals 750-1125 mg once daily. 1

Ceftriaxone can be administered either intravenously (IV) or intramuscularly (IM) depending on the clinical situation:

  • For most infections: 50 mg/kg/day as a single daily dose
  • For more severe infections: 75 mg/kg/day as a single daily dose
  • Maximum daily dose: generally not to exceed 2 grams

The long half-life of ceftriaxone (5.2-8.4 hours in infants) allows for once-daily dosing, which is a significant advantage in pediatric patients 2.

Administration Considerations:

  • IV administration should be given over 30 minutes
  • IM injections should be limited to 1 g per injection site
  • Should not be used in hyperbilirubinemic neonates 1

Aciclovir (Acyclovir) Dosing

For a 15 kg child with suspected herpes virus infection, the recommended dose of aciclovir is 250-500 mg/m² or 10-20 mg/kg every 8 hours intravenously. 3

For a typical 15 kg child (approximately 0.6-0.65 m² body surface area):

  • Standard dose: 150-300 mg every 8 hours (10-20 mg/kg)
  • Duration of therapy depends on the type of infection:
    • Mucocutaneous HSV: 5-7 days
    • Encephalitis: 14-21 days
    • Disseminated disease: 14-21 days

Administration Considerations:

  • Aciclovir IV should be administered by slow infusion over at least 1 hour to prevent renal tubular damage
  • Maintain adequate hydration during treatment
  • Monitor renal function, especially in neonates and young infants

Monitoring Recommendations

For Ceftriaxone:

  • No routine drug level monitoring required
  • Monitor for clinical response within 48-72 hours
  • Watch for signs of biliary sludging with prolonged use
  • Consider monitoring CBC, liver and renal function with prolonged therapy

For Aciclovir:

  • Monitor renal function before and during therapy
  • Ensure adequate hydration
  • Adjust dose in case of renal impairment
  • Monitor for neurological adverse effects (tremors, confusion)

Important Precautions

  1. Ceftriaxone:

    • Do not mix or administer simultaneously with calcium-containing solutions
    • Watch for diarrhea (possible C. difficile infection)
    • Monitor for hypersensitivity reactions
  2. Aciclovir:

    • Ensure proper dilution to prevent crystalluria
    • Slower infusion rate in patients with renal impairment
    • Monitor for neurotoxicity, especially with high doses or renal impairment

Clinical Pearls

  • Ceftriaxone's once-daily dosing improves compliance and reduces nursing time 4
  • Aciclovir should be started as early as possible in suspected herpes infections for optimal outcomes
  • Both medications have excellent CNS penetration when needed for meningitis or encephalitis
  • For most pediatric infections, ceftriaxone at 50 mg/kg/day is sufficient, with higher doses (75 mg/kg/day) reserved for meningitis or severe infections 5

Remember to adjust dosing based on clinical response and specific infection being treated.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ceftriaxone pharmacokinetics in newborn infants.

Antimicrobial agents and chemotherapy, 1983

Research

Ceftriaxone for the treatment of serious infections.

American journal of diseases of children (1960), 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.